Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(+)-5-Iodo-2'-deoxyuridine, also known as Idoxuridine, is a nucleoside analog that inhibits the replication of viruses and other DNA-containing organisms. It is a pyrimidine 2'-deoxyribonucleoside compound with 5-iodouracil as the nucleobase. This crystalline solid has been used as an antiviral agent and has inhibitory properties on cell nuclei, which may be due to its ability to bind with DNA and prevent the synthesis of RNA or protein.

54-42-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5-Iodo-2-Deoxyuridine 5-IDU CAS NO.54-42-2 Pharma intermediate worldwide TOP pharma factory vendor

    Cas No: 54-42-2

  • USD $ 2000.0-2500.0 / Kilogram

  • 1 Kilogram

  • 100 Kilogram/Month

  • YUNBIO TECH CO.,LTD
  • Contact Supplier
  • 54-42-2 Structure
  • Basic information

    1. Product Name: (+)-5-Iodo-2'-deoxyuridine
    2. Synonyms: DENDRID;EMANIL;IDU;IDOXURIDINE;IUDR;2'-DEOXY-5-IODOURIDINE;1-(2-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODOURACIL;5-IODO-2'-DEOXY-D-URIDINE
    3. CAS NO:54-42-2
    4. Molecular Formula: C9H11IN2O5
    5. Molecular Weight: 354.1
    6. EINECS: 200-207-8
    7. Product Categories: Amino Acids;Heterocyclic Compounds;Antivirals for Research and Experimental Use;Biochemistry;Chemical Reagents for Pharmacology Research;Nucleosides and their analogs;Nucleosides, Nucleotides & Related Reagents;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;CYTOVENE
    8. Mol File: 54-42-2.mol
  • Chemical Properties

    1. Melting Point: 194 °C(lit.)
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: White to slightly beige/Crystalline Powder
    5. Density: 1.7911 (estimate)
    6. Refractive Index: 30 ° (C=1, 1mol/L NaOH)
    7. Storage Temp.: 2-8°C
    8. Solubility: DMSO (Slightly, Sonicated), Methanol (Slightly, Heated, Sonicated), Water (Sligh
    9. PKA: 8.25(at 25℃)
    10. Water Solubility: 1.6 g/L (20 ºC)
    11. Sensitive: Air & Light Sensitive
    12. Merck: 14,4891
    13. BRN: 30397
    14. CAS DataBase Reference: (+)-5-Iodo-2'-deoxyuridine(CAS DataBase Reference)
    15. NIST Chemistry Reference: (+)-5-Iodo-2'-deoxyuridine(54-42-2)
    16. EPA Substance Registry System: (+)-5-Iodo-2'-deoxyuridine(54-42-2)
  • Safety Data

    1. Hazard Codes: T,Xn
    2. Statements: 45-46-61-40-68-62-36/37/38-63
    3. Safety Statements: 53-45-36-22-36/37-26
    4. WGK Germany: 3
    5. RTECS: YU7700000
    6. F: 8-23
    7. TSCA: Yes
    8. HazardClass: N/A
    9. PackingGroup: N/A
    10. Hazardous Substances Data: 54-42-2(Hazardous Substances Data)

54-42-2 Usage

Uses

Used in Antiviral Applications:
(+)-5-Iodo-2'-deoxyuridine is used as an antiviral agent for its effectiveness against herpes-simplex infections. It is commonly found in ophthalmic eyedrops, ointments, and solutions to treat these infections.
Used in Antitumor Applications:
(+)-5-Iodo-2'-deoxyuridine is used as an antitumor nucleoside enantiomer thymidine kinase, which has potential antiviral applications. It acts as a cytotoxic analog of thymidine, inhibiting nucleic acid synthesis and thus, displaying antiviral properties.
Used in Pharmaceutical Industry:
(+)-5-Iodo-2'-deoxyuridine is used as an active pharmaceutical ingredient in various brand-name medications, such as Dendrrid (Alcon), Herplex (Allergan), and Stoxil (GlaxoSmithKline), targeting antiviral and antitumor treatments.

Originator

Dendrid,Alcon,US,1963

Indications

Idoxuridine (Herplex) is a water-soluble iodinated derivative of deoxyuridine that inhibits several DNA viruses including HSV, VZV, vaccinia, and polyoma virus. The triphosphorylated metabolite of idoxuridine inhibits both viral and cellular DNA synthesis and is also incorporated into DNA. Such modified DNA is susceptible to strand breakage and causes aberrant viral protein synthesis. Because of its significant host cytotoxicity, idoxuridine cannot be used to treat systemic viral infections. The development of resistance to this drug is common.

Manufacturing Process

5 g of 5-iodo-uracil (obtained according to T.B. Johnson et al., J. Biol. Chem. 1905/6, 1, 310) in 15 cc of acetic anhydride are heated under reflux for 4,5 hours. The acetylated derivative crystallizes on cooling. The crystallized product is chilled for ? hour then filtered with suction, washed with acetic anhydride and then with ether and dried. 4.5 g of 1-acetyl-5-iodo-uracil, MP 167°C, are thus obtained. 1.51 g of mercuric acetate are dissolved in 50 cc of methanol under reflux and 1.35 g of 1-acetyl-5-iodo-uracilare added. A white precipitate is soon formed. The reaction mixture is kept under reflux for % hour and then allowed to cool to room temperature. The precipitate is then filtered with suction, washed with methanol and dried. 2.1 g of monomercuric 5-iodo-uracil, MP 280°C, are thus obtained as a colorless powder, insoluble in water and the majority of the usual organic solvents, such as benzene, chloroform, alcohol, ether and acetone. 1.46 g of 5-iodo-uracil monomercuric derivative are introduced into 50 cc of chloroform and 20 to 30 cc of the solvent are distilled off under normal pressure to ensure good dehydration of the reaction medium. The mixture is cooled to room temperature and 2.59 g of 3,5-di-p-toluyl-desoxy-Dribofuranosyl chloride added. The mixture is agitated for 6 hours with glass balls, filtered, rinsed with chloroform and the filtrate is successively washed with an aqueous sodium iodide solution, with water, with a saturated solution of sodium bicarbonate and again with water. The product is dried over sodium sulfate, filtered and evaporated to dryness. The residue crystallizes in ether and yields about 600 mg of β-3',5'-di-ptoluyl-2'-desoxy-5-iodo-uridine which is recrystallized from toluene. The product is obtained as colorless crystals, soluble in chloroform and pyridine, sparingly soluble in acetone, benzene ether and alcohol, insoluble in water, MP 193°C. 206 mg of 3',5'-di-p-toluyl-2'-desoxy-5-iodo-uridineare heated at 80°C with 2.5 cc of caustic soda solution (0.4 N) for ? hour. The solution obtained is cooled, filtered and then acidified with acetic acid. The desoxy-iodo-uridine and the p-toluic acid crystallize. Ether is added to dissolve the p-toluic acid, the mixture is chilled, filtered with suction, washed with water and ether, and dried. The residue is recrystallized from water and 100 mg of 5-iodo-2'- desoxy-uridine, are obtained.

Therapeutic Function

Antiviral (ophthalmic)

Pharmaceutical Applications

A halogenated pyrimidine analog originally synthesized as an anticancer agent. Formulated in dimethylsulfoxide for topical application and as a solution for ophthalmic use. Activity is largely limited to DNA viruses, primarily HSV-1, HSV-2 and VZV. HSV-1 plaque formation in BHK 21 cells is sensitive to 6.25–25 mg/L; type 2 microplaques required 62.5–125 mg/L. RNA viruses are not affected, with the exception of oncogenic RNA viruses such as Rous sarcoma virus. Drug resistance is easily generated in vitro, and may be an obstacle to treatment. However, there is little or no crossresistance with newer nucleoside analogs. It is poorly soluble in water, and aqueous solutions are ineffective against infections other than those localized to the eye. In animals, therapeutic levels are achieved in the cornea within 30 min of ophthalmic application and persist for 4 h. Penetration is otherwise poor, with only the biologically inactive dehalogenated metabolite uracil entering the eye. The drug is too toxic for systemic administration. Contact dermatitis, punctate epithelial keratopathy, follicular conjunctivitis, ptosis, stenosis and occlusion of the puncta and keratinization of the lid margins occur in up to 14% of those receiving ophthalmic preparations. It is used in herpes keratitis, but has largely been superseded by trifluridine or aciclovir.

Biochem/physiol Actions

5-Iodo-2′-deoxyuridine prevents in vitro DNA viral replication. This is observed in herpesviruses and poxviruses It might possess teratogenic, tumor-promoting, mutagenic, and immunosuppressive properties. 5-Iodo-2′-deoxyuridine, used in topical applications, is effective against epithelial infections.

Mechanism of action

Idoxuridine is a nucleoside containing a halogenated pyrimidine and is an analogue of thymidine. It acts as an antiviral agent against DNA viruses by interfering with their replication based on the similarity of structure between thymidine and idoxuridine. Idoxuridine is first phosphorylated by the host cell virusencoded enzyme thymidine kinase to an active triphosphate form. The phosphorylated drug inhibits cellular DNA polymerase to a lesser extent than HSV DNA polymerase, which is necessary for the synthesis of viral DNA. The triphosphate form of the drug is then incorporated during viral nucleic acid synthesis by a false pairing system that replaces thymidine. When transcription occurs, faulty viral proteins are formed, resulting in defective viral particles.

Clinical Use

The only FDA-approved use of idoxuridine is in the treatment of herpes simplex infections of the eyelid, conjunctiva conjunctiva, and cornea. It is most effective against surface infections because it has little ability to penetrate the tissues of the eye. intravenous idoxuridine was designated an orphan drug for the treatment of soft tissue sarcoma.

Side effects

Idoxuridine may cause local irritation, mild edema, itching, and photophobia. Corneal clouding and small punctate defects in the corneal epithelium have been reported. Allergic reactions are rare.

Safety Profile

Moderately toxic by intraperitoneal route. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental carcinogenic data. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Iand NOx.

Synthesis

Idoxuridine, 5-iodo-1-(2-deoxyyribofuranosyl)pyrimidin-2,4-(1H.3H)-dione (36.1.14), is synthesized by the following scheme. 5-Iodouracil is acylated with acetic anhydride to make 1-acetyl-5-iodouracil (36.1.11). Treating this with mercury(II) acetate gives 5-iodomonomercury uracil (36.1.12), which is reacted with 1-bromodidesoxy-D-ribofuranosyl-3,5-bis-(p-toluenesulfonate) to make a ditosyl derivative (36.1.13). Hydrolysis of the tosyl groups using sodium hydroxide and subsequent treatment of the resulting substance with acetic acid gives the desired product idoxuridine.

Veterinary Drugs and Treatments

Idoxuridine (IDU) is chemically similar to thymidine and its substitution into viral DNA causes misreading of the viral genetic code thereby inhibiting viral replication. Like trifluridine, IDU is considered virostatic rather than viricidal. IDU was found to be second to trifluridine in efficacy in vitro against common strains of feline herpes virus growing in kidney epithelial cells. IDU is extremely well tolerated in cats and this feature alone makes it the most popular antiviral currently available for use in cats with presumed or established feline herpes virus infection. Although trifluridine was shown to be more effective in vitro, the topical irritation it induces in cats frequently negates any beneficial effect that might be noted clinically. Stinging upon application is a rare feature with IDU/artificial tear preparations.

Check Digit Verification of cas no

The CAS Registry Mumber 54-42-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 54-42:
(4*5)+(3*4)+(2*4)+(1*2)=42
42 % 10 = 2
So 54-42-2 is a valid CAS Registry Number.

54-42-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (I0258)  5-Iodo-2'-deoxyuridine  >99.0%(T)

  • 54-42-2

  • 1g

  • 550.00CNY

  • Detail
  • TCI America

  • (I0258)  5-Iodo-2'-deoxyuridine  >99.0%(T)

  • 54-42-2

  • 5g

  • 1,850.00CNY

  • Detail
  • TCI America

  • (I0258)  5-Iodo-2'-deoxyuridine  >99.0%(T)

  • 54-42-2

  • 25g

  • 6,450.00CNY

  • Detail
  • Alfa Aesar

  • (A11542)  (+)-5-Iodo-2'-deoxyuridine, 98%   

  • 54-42-2

  • 1g

  • 607.0CNY

  • Detail
  • Alfa Aesar

  • (A11542)  (+)-5-Iodo-2'-deoxyuridine, 98%   

  • 54-42-2

  • 5g

  • 2453.0CNY

  • Detail
  • USP

  • (1336001)  Idoxuridine  United States Pharmacopeia (USP) Reference Standard

  • 54-42-2

  • 1336001-250MG

  • 4,662.45CNY

  • Detail

54-42-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-iodo-2'-deoxyuridine

1.2 Other means of identification

Product number -
Other names Idoxuridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54-42-2 SDS

54-42-2Synthetic route

2'-deoxyuridine
951-78-0

2'-deoxyuridine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With iodine; silver nitrate In methanol at 40℃; for 3h;100%
With iodine; silver nitrate In methanol at 40℃; for 3h;100%
With sodium azide; Iodine monochloride In acetonitrile at 25℃; for 24h; Product distribution; Mechanism; other uracil nucleosides; other halogenation agents; var. temp. and time;96%
3',5'-O-diacetyl-5-iodo-2'-deoxyuridine
1956-30-5

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With sodium methylate In methanol for 1h; Ambient temperature;90%
With methanol; sodium methylate at 20℃; for 1h;
5-trimethylstannyl-2'-deoxyuridine
146629-34-7

5-trimethylstannyl-2'-deoxyuridine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide; acetic acid; sodium iodide In chloroform for 0.00416667h; Irradiation;
C23H17Cl2IN2O7

C23H17Cl2IN2O7

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With ammonia In methanol at 30℃; for 16h;
2'-deoxyuridine
951-78-0

2'-deoxyuridine

5-iodouracil
696-07-1

5-iodouracil

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
at 37℃; for 6h; alginate gel-entrapped cells of auxotrophic thymine-dependent strain of E. coli, ammonium acetate buffer pH 5.8;
5-iodouracil
696-07-1

5-iodouracil

thymidine
50-89-5

thymidine

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

thymin
65-71-4

thymin

Conditions
ConditionsYield
With thymidine phosphorylase from Escherichia coli In phosphate buffer at 35℃; for 2h; pH=7.0; Title compound not separated from byproducts;A 88 % Chromat.
B n/a
3',5'-di-O-acetyl-2'-deoxyuridine
13030-62-1

3',5'-di-O-acetyl-2'-deoxyuridine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / LiI, ceric ammonium nitrate (CAN) / acetonitrile / 1 h / 80 °C / other conditions and reagents investigated
2: 90 percent / 0.1 M NaOMe / methanol / 1 h / Ambient temperature
View Scheme
C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril
51592-06-4

1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With sodium iodide In water
2'-deoxyuridine
951-78-0

2'-deoxyuridine

5-iodouracil
696-07-1

5-iodouracil

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

uracil
66-22-8

uracil

Conditions
ConditionsYield
With thymidine phosphorylase from Escherichia coli (E.C. 2.4.2.4) immobilized on Sepabeads EC-EP In aq. phosphate buffer at 20℃; for 3h; pH=7.5; Reagent/catalyst; Enzymatic reaction;
3',5'-di-O-acetyl-2'-deoxyuridine
13030-62-1

3',5'-di-O-acetyl-2'-deoxyuridine

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

C9H11IN2O5S

C9H11IN2O5S

C

C18H20I2N4O8S2

C18H20I2N4O8S2

D

C18H21IN4O8S2

C18H21IN4O8S2

E

2'-deoxy-4-thiouridine
5580-20-1

2'-deoxy-4-thiouridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ammonium cerium (IV) nitrate; iodine / acetonitrile / 1 h / 80 °C
2: tetraphosphorus decasulfide / 1,4-dioxane / Reflux
3: sodium hydride / methanol / 0.17 h / 0 - 20 °C
4: aq. phosphate buffer; tert-butyl alcohol / Radiolysis
View Scheme
3',5'-O-diacetyl-5-iodo-2'-deoxyuridine
1956-30-5

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

C9H11IN2O5S

C9H11IN2O5S

C

C18H20I2N4O8S2

C18H20I2N4O8S2

D

C18H21IN4O8S2

C18H21IN4O8S2

E

2'-deoxy-4-thiouridine
5580-20-1

2'-deoxy-4-thiouridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tetraphosphorus decasulfide / 1,4-dioxane / Reflux
2: sodium hydride / methanol / 0.17 h / 0 - 20 °C
3: aq. phosphate buffer; tert-butyl alcohol / Radiolysis
View Scheme
5-iodo-4-thio-2'-deoxyuridine
1313407-40-7

5-iodo-4-thio-2'-deoxyuridine

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

C9H11IN2O5S

C9H11IN2O5S

C

C18H20I2N4O8S2

C18H20I2N4O8S2

D

C18H21IN4O8S2

C18H21IN4O8S2

E

2'-deoxy-4-thiouridine
5580-20-1

2'-deoxy-4-thiouridine

Conditions
ConditionsYield
In aq. phosphate buffer; tert-butyl alcohol Radiolysis;
2'-deoxyuridine
951-78-0

2'-deoxyuridine

A

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

B

C9H11IN2O5S

C9H11IN2O5S

C

C18H20I2N4O8S2

C18H20I2N4O8S2

D

C18H21IN4O8S2

C18H21IN4O8S2

E

2'-deoxy-4-thiouridine
5580-20-1

2'-deoxy-4-thiouridine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: pyridine / 24 h / 20 °C
2: ammonium cerium (IV) nitrate; iodine / acetonitrile / 1 h / 80 °C
3: tetraphosphorus decasulfide / 1,4-dioxane / Reflux
4: sodium hydride / methanol / 0.17 h / 0 - 20 °C
5: aq. phosphate buffer; tert-butyl alcohol / Radiolysis
View Scheme
5-iodouracil
696-07-1

5-iodouracil

thymidine
50-89-5

thymidine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With recobinant purine nucleoside phosphorylase from Escherichia coli In aq. phosphate buffer pH=6.8; Heating; Enzymatic reaction;
C5H9O7P(2-)*2K(1+)

C5H9O7P(2-)*2K(1+)

5-iodouracil
696-07-1

5-iodouracil

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

Conditions
ConditionsYield
With E-pyrimidine nucleoside phosphorylase-0002 In aq. buffer at 50℃; for 2h; pH=9; Equilibrium constant; Enzymatic reaction;
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

methyl (E)-3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate
86163-17-9

methyl (E)-3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate

Conditions
ConditionsYield
With palladium diacetate; triethylamine; triphenylphosphine In 1,4-dioxane for 14h; Heating;100%
Stage #1: 5-Iodo-2'-deoxyuridine With C26H32N8O6P2PdS2 In acetonitrile at 80℃; for 0.0833333h; Heck Reaction; Inert atmosphere;
Stage #2: acrylic acid methyl ester With triethylamine In acetonitrile at 80℃; for 8h; Heck Reaction; Inert atmosphere;
92%
With palladium diacetate; triethylamine; triphenylphosphine In N,N-dimethyl-formamide at 100℃; for 1h;87%
9-ethynyl-closo-1,7-dodecaborane
80755-88-0

9-ethynyl-closo-1,7-dodecaborane

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-[(1,7-dicarba-closo-dodecaboran-9-yl)ethyn-1-yl]-2′-deoxyuridine

5-[(1,7-dicarba-closo-dodecaboran-9-yl)ethyn-1-yl]-2′-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; tetrakis(triphenylphosphine) palladium(0); triethylamine In N,N-dimethyl-formamide at 80℃; Sonogashira Cross-Coupling; Inert atmosphere;100%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

2'-deoxy-3',5'-bis(O-tert-butyldimethylsilyl)-5-iodouridine
148134-86-5

2'-deoxy-3',5'-bis(O-tert-butyldimethylsilyl)-5-iodouridine

Conditions
ConditionsYield
With 1H-imidazole In pyridine for 33h;99%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 3h;99.8%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 60h;99%
4,4'-dimethoxytrityl chloride
40615-36-9

4,4'-dimethoxytrityl chloride

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-iodouridine
104375-88-4

2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-iodouridine

Conditions
ConditionsYield
With pyridine Ambient temperature;99%
With pyridine; triethylamine at 20℃; for 1h;98%
With pyridine In triethylamine at 20℃; for 5h;96%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

acetic anhydride
108-24-7

acetic anhydride

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine
1956-30-5

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine

Conditions
ConditionsYield
With pyridine at 20℃; for 16.5h;99%
With pyridine at 20℃;98%
With pyridine at 25℃; for 20h;97%
3,3-bis-(trifluoromethyl)-4,4,4-trifluoro-1-butyne
14115-48-1

3,3-bis-(trifluoromethyl)-4,4,4-trifluoro-1-butyne

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl)-2'-deoxyuridine
1032735-58-2

5-(4,4,4-trifluoro-3,3-bis(trifluoromethyl)but-1-ynyl)-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; tetrakis(triphenylphosphine) palladium(0); N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 22℃; for 96h; Sonogashira coupling; Inert atmosphere;98%
acrylic acid n-butyl ester
141-32-2

acrylic acid n-butyl ester

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

(E)-5-[2-(n-butyloxycarbonyl)vinyl]-2′-deoxyuridine

(E)-5-[2-(n-butyloxycarbonyl)vinyl]-2′-deoxyuridine

Conditions
ConditionsYield
With 3,3′,3″-phosphinetriyltribenzenesulfonate; palladium diacetate; triethylamine In water; acetonitrile at 80℃; for 1.5h; Solvent; Temperature; Reagent/catalyst; Inert atmosphere;98%
With tri(3-sulfonatophenyl)phosphine trisodium salt; palladium diacetate; triethylamine In water; acetonitrile at 80℃; Heck reaction; Inert atmosphere;74%
methanol
67-56-1

methanol

carbon monoxide
201230-82-2

carbon monoxide

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-methoxycarbonyl-2’-deoxyuridine

5-methoxycarbonyl-2’-deoxyuridine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); triethylamine; triphenylphosphine In N,N-dimethyl-formamide at 70℃;98%
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-iodo-3',5'-O-[(tetraisopropyl)disiloxane-1,3-diyl]-2'-deoxyuridine
129507-76-2

5-iodo-3',5'-O-[(tetraisopropyl)disiloxane-1,3-diyl]-2'-deoxyuridine

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide for 12h;97%
With pyridine at 20℃;97%
With pyridine at 20℃;84%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 3h; silylation;
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

phenylboronic acid
98-80-6

phenylboronic acid

1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-phenylpyrimidine-2,4(1H,3H)-dione
76756-28-0

1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-phenylpyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With palladium diacetate; sodium carbonate; triphenylphosphine In water; acetonitrile at 70 - 80℃; for 4h; Suzuki-Miyaura Coupling; Inert atmosphere;97%
With palladium diacetate; sodium carbonate; triphenylphosphine In water; acetonitrile at 70 - 80℃; for 4h; Suzuki-Miyaura Coupling; Inert atmosphere;97%
With C30H24Cl2N2O10Pd2S2(2-)*2Na(1+); triethylamine In water at 60℃; for 3h; Suzuki-Miyaura Coupling; Inert atmosphere; Schlenk technique;93%
2-ethynylpyridine
1945-84-2

2-ethynylpyridine

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(2-pyridylethynyl)-2'-deoxyuridine
78824-48-3

5-(2-pyridylethynyl)-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; tetrakis(triphenylphosphine) palladium(0); N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;97%
1-Heptene
592-76-7

1-Heptene

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(hept-1-en-1-yl)-2'-deoxyuridine
96962-44-6

5-(hept-1-en-1-yl)-2'-deoxyuridine

Conditions
ConditionsYield
With tributyl-amine; palladium diacetate In N,N-dimethyl-formamide at 100℃; for 0.333333h; Heck reaction; Microwave irradiation;97%
With tributyl-amine; palladium diacetate In 1,4-dioxane; N,N-dimethyl-formamide at 100℃; for 0.333333h; Microwave irradiation;97%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

2-(tri-n-butylstannyl)benzofuran

2-(tri-n-butylstannyl)benzofuran

5-(benzofuran-2-yl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
1449768-52-8

5-(benzofuran-2-yl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride In 1,4-dioxane at 90℃; Stille Cross Coupling;97%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

but-1-yn-4-yl thiobenzoate
211510-45-1

but-1-yn-4-yl thiobenzoate

5-(4-benzoylthio-1-butynyl)-2'-deoxyuridine
647852-33-3

5-(4-benzoylthio-1-butynyl)-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 22 - 24℃;96%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

acetyl chloride
75-36-5

acetyl chloride

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine
1956-30-5

3',5'-O-diacetyl-5-iodo-2'-deoxyuridine

Conditions
ConditionsYield
With acetic anhydride; acetic acid 1.) 0 deg C, 1 h, 2.) RT, 24 h;95%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

dimethyl sulfate
77-78-1

dimethyl sulfate

5-iodo-3-methyl-2′-deoxyuridine
35695-25-1

5-iodo-3-methyl-2′-deoxyuridine

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 0.166667h;95%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

3-methyl-N-(prop-2-yn-1-yl)butanamide
422284-33-1

3-methyl-N-(prop-2-yn-1-yl)butanamide

5-[3-(3-methylbutyrylamino)prop-1-ynyl]-2'-deoxyuridine

5-[3-(3-methylbutyrylamino)prop-1-ynyl]-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; tetrakis(triphenylphosphine) palladium(0); triethylamine In N,N-dimethyl-formamide at 20℃; for 4h;95%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

diphenylphosphane
829-85-6

diphenylphosphane

5-diphenylphosphine-2'-deoxyuridine
939057-19-9

5-diphenylphosphine-2'-deoxyuridine

Conditions
ConditionsYield
With triethylamine; palladium diacetate In N,N-dimethyl-formamide at 60℃; for 0.5h;95%
3-methoxyphenylboronic acid
10365-98-7

3-methoxyphenylboronic acid

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(3-methoxyphenyl)-2'-deoxyuridine
92510-79-7

5-(3-methoxyphenyl)-2'-deoxyuridine

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); cesium fluoride In water; N,N-dimethyl-formamide at 60℃; Suzuki cross-coupling; Inert atmosphere;95%
With [Pd(phthalimidate)2(1,3,5-triaza-7-phosphaadamantane)2]; triethylamine In water at 20 - 80℃; for 6h; Suzuki-Miyaura Coupling; Inert atmosphere;
4-tert-Butylphenylacetylene
772-38-3

4-tert-Butylphenylacetylene

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-((4-tert-butylphenyl)ethynyl)-2'-deoxyuridine
596107-17-4

5-((4-tert-butylphenyl)ethynyl)-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 40℃; for 25h; Sonogashira coupling;94%
With copper(l) iodide; tetra-(n-butyl)ammonium iodide; triphenylphosphine; tetrakis(triphenylphosphine) palladium(0); triethylamine In N,N-dimethyl-formamide at 20℃; for 24h; Sonogashira coupling;76%
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

2-(tributylstannyl)furan
118486-94-5

2-(tributylstannyl)furan

5-furan-2-yl-1-(β-D-2-deoxyribofuranos-1-yl)uracil
92233-50-6

5-furan-2-yl-1-(β-D-2-deoxyribofuranos-1-yl)uracil

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride In 1,4-dioxane at 90℃; for 2h; Stille coupling;94%
bis-triphenylphosphine-palladium(II) chloride In 1,4-dioxane at 90℃; for 2h; Stille coupling;94%
With bis-triphenylphosphine-palladium(II) chloride In 1,4-dioxane94%
With bis-triphenylphosphine-palladium(II) chloride In 1,4-dioxane at 90℃; Stille Cross Coupling;
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

1-Ethynyl-1-cyclohexanol
78-27-3

1-Ethynyl-1-cyclohexanol

5-((1-hydroxycyclohexyl)ethynyl)-2'-deoxyuridine
936332-87-5

5-((1-hydroxycyclohexyl)ethynyl)-2'-deoxyuridine

Conditions
ConditionsYield
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 50℃; for 7h; Sonogashira coupling;94%
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide
2-Methylphenylboronic acid
16419-60-6

2-Methylphenylboronic acid

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(2-methylphenyl)-2'-deoxyuridine
1373213-45-6

5-(2-methylphenyl)-2'-deoxyuridine

Conditions
ConditionsYield
With sodium tetrachloropalladate; trisodium tris(3-sulfophenyl)phosphine; potassium hydroxide In water at 100℃; for 24h; Suzuki-Miyaura coupling; Inert atmosphere;94%
With sodium tetrachloropalladate(II); potassium hydroxide In water at 100℃; for 1h; Suzuki-Miyaura Coupling; Inert atmosphere; Microwave irradiation;30%
With sodium tetrachloropalladate(II); potassium hydroxide In water at 100℃; for 24h; Concentration; Time; Suzuki-Miyaura Coupling; Inert atmosphere; Green chemistry;22%
benzofuran-2-boronic acid
98437-24-2

benzofuran-2-boronic acid

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(benzofuran-2-yl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
1449768-52-8

5-(benzofuran-2-yl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With [Pd(succinimidate)2(1,3,5-triaza-7-phosphaadamantane)2]; triethylamine In water at 80℃; for 0.0833333h; Catalytic behavior; Concentration; Suzuki-Miyaura Coupling; Microwave irradiation; Inert atmosphere;94%
With C30H24Cl2N2O10Pd2S2(2-)*2Na(1+); triethylamine In water at 60℃; for 3h; Solvent; Reagent/catalyst; Temperature; Suzuki-Miyaura Coupling; Inert atmosphere; Schlenk technique;89%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

propionic acid anhydride
123-62-6

propionic acid anhydride

3′,5′-bis-O-propionyl-5-iodo-2′-deoxyuridine
4833-05-0

3′,5′-bis-O-propionyl-5-iodo-2′-deoxyuridine

Conditions
ConditionsYield
With pyridine at 60℃; for 8h; Inert atmosphere;93%
With pyridine85%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

tri-n-butyl(vinyl)tin
7486-35-3

tri-n-butyl(vinyl)tin

5-vinyl-2'-deoxyuridine
55520-67-7

5-vinyl-2'-deoxyuridine

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran for 12h; Inert atmosphere; Reflux;92%
With bis-triphenylphosphine-palladium(II) chloride In tetrahydrofuran for 24h; Inert atmosphere; Reflux;50%
With bis-triphenylphosphine-palladium(II) chloride In tetrahydrofuran for 24h; Heating;47%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

trimethylsilylacetylene
1066-54-2

trimethylsilylacetylene

1-(2-deoxy-β-D-ribofuranosyl)-5-[2-(trimethylsilyl)ethynyl]uracil
151362-01-5

1-(2-deoxy-β-D-ribofuranosyl)-5-[2-(trimethylsilyl)ethynyl]uracil

Conditions
ConditionsYield
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 55℃; for 24h; Sonogashira coupling;92%
With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; triethylamine In acetonitrile at 50℃; for 3.5h; Schlenk technique; Inert atmosphere;85%
With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; triethylamine In acetonitrile for 3.5h; Inert atmosphere; Heating;82%
4-fluoroboronic acid
1765-93-1

4-fluoroboronic acid

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

5-(4'-fluorophenyl)-2'-deoxyuridine

5-(4'-fluorophenyl)-2'-deoxyuridine

Conditions
ConditionsYield
With palladium diacetate; sodium carbonate; tris-(m-sulfonatophenyl)phosphine In water; acetonitrile at 80℃; Suzuki coupling;92%
With tetrakis(triphenylphosphine) palladium(0); cesium fluoride In water; N,N-dimethyl-formamide at 60℃; Suzuki cross-coupling; Inert atmosphere;78%
With palladium diacetate; sodium carbonate; triphenylphosphine In water at 120℃; for 0.166667h; Suzuki-Miyaura Coupling; Inert atmosphere; Sealed tube; Microwave irradiation;74%
With [Pd(phthalimidate)2(1,3,5-triaza-7-phosphaadamantane)2]; triethylamine In water at 20 - 80℃; for 6h; Suzuki-Miyaura Coupling; Inert atmosphere;
methyl 3-ethynylbenzoate
10602-06-9

methyl 3-ethynylbenzoate

5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

3-[3-((2R,4S,5R)-4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-2,3-dihydro-furo[2,3-d]pyrimidin-6-yl]-benzoic acid methyl ester

3-[3-((2R,4S,5R)-4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-2,3-dihydro-furo[2,3-d]pyrimidin-6-yl]-benzoic acid methyl ester

Conditions
ConditionsYield
With copper(l) iodide; triethylamine; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 55℃; for 12h;92%

54-42-2Relevant articles and documents

Synthesis of Phosphoramidite Monomers Equipped with Complementary Bases for Solid-Phase DNA Oligomerization

Romero-Pérez, Sonia,López-Martín, Isabel,Martos-Maldonado, Manuel C.,Somoza, álvaro,González-Rodríguez, David

supporting information, p. 41 - 45 (2020/01/03)

We describe the preparation of two monomers that bear complementary nucleobases at the edges (guanine-2′-deoxycytidine and 2-aminoadenine-2′-deoxyuridine) and that are conveniently protected and activated for solid-phase automated DNA synthesis. We report the optimized synthetic routes leading to the four nucleobase derivatives involved, their cross-coupling reactions into dinucleobase-containing monomers, and their oligomerization in the DNA synthesizer.

Thermodynamic Reaction Control of Nucleoside Phosphorolysis

Kaspar, Felix,Giessmann, Robert T.,Neubauer, Peter,Wagner, Anke,Gimpel, Matthias

supporting information, p. 867 - 876 (2020/01/24)

Nucleoside analogs represent a class of important drugs for cancer and antiviral treatments. Nucleoside phosphorylases (NPases) catalyze the phosphorolysis of nucleosides and are widely employed for the synthesis of pentose-1-phosphates and nucleoside analogs, which are difficult to access via conventional synthetic methods. However, for the vast majority of nucleosides, it has been observed that either no or incomplete conversion of the starting materials is achieved in NPase-catalyzed reactions. For some substrates, it has been shown that these reactions are reversible equilibrium reactions that adhere to the law of mass action. In this contribution, we broadly demonstrate that nucleoside phosphorolysis is a thermodynamically controlled endothermic reaction that proceeds to a reaction equilibrium dictated by the substrate-specific equilibrium constant of phosphorolysis, irrespective of the type or amount of NPase used, as shown by several examples. Furthermore, we explored the temperature-dependency of nucleoside phosphorolysis equilibrium states and provide the apparent transformed reaction enthalpy and apparent transformed reaction entropy for 24 nucleosides, confirming that these conversions are thermodynamically controlled endothermic reactions. This data allows calculation of the Gibbs free energy and, consequently, the equilibrium constant of phosphorolysis at any given reaction temperature. Overall, our investigations revealed that pyrimidine nucleosides are generally more susceptible to phosphorolysis than purine nucleosides. The data disclosed in this work allow the accurate prediction of phosphorolysis or transglycosylation yields for a range of pyrimidine and purine nucleosides and thus serve to empower further research in the field of nucleoside biocatalysis. (Figure presented.).

Site-specific incorporation of multiple units of functional nucleotides into DNA using a step-wise approach with polymerase and its application to monitoring DNA structural changes

Huy Le, Binh,Nguyen, Van Thang,Seo, Young Jun

supporting information, p. 2158 - 2161 (2019/02/20)

We have developed a new method, a step-wise approach with polymerase, for site-specific incorporation of multiple units of functional nucleotides into DNA to form hairpin secondary structures. The fluorescence of the resulting DNA incorporating the functional nucleotides varied upon transitioning from single-strand to hairpin and duplex structures.

Bio-catalytic synthesis of unnatural nucleosides possessing a large functional group such as a fluorescent molecule by purine nucleoside phosphorylase

Hatano, Akihiko,Wakana, Hiroyuki,Terado, Nanae,Kojima, Aoi,Nishioka, Chisato,Iizuka, Yu,Imaizumi, Takuya,Uehara, Sanae

, p. 5122 - 5129 (2019/10/05)

Unnatural nucleosides are attracting interest as potential diagnostic tools, medicines, and functional molecules. However, it is difficult to couple unnatural nucleobases to the 1′-position of ribose in high yield and with β-regioselectivity. Purine nucleoside phosphorylase (PNP, EC2.4.2.1) is a metabolic enzyme that catalyses the conversion of inosine to ribose-1α-phosphate and free hypoxanthine in phosphate buffer with 100% α-selectivity. We explored whether PNP can be used to synthesize unnatural nucleosides. PNP catalysed the reaction of thymidine as a ribose donor with purine to produce 2′-deoxynebularine (3, β form) in high conversion (80%). It also catalysed the phosphorolysis of thymidine and introduced a pyrimidine base with a halogen atom substituted at the 5-position into the 1′-position of ribose in moderate yield (52-73%), suggesting that it exhibits loose selectivity. For a bulky purine substrate [e.g., 6-(N,N-di-propylamino)], the yield was lower, but addition of a polar solvent such as dimethyl sulfoxide (DMSO) increased the yield to 74%. PNP also catalysed the reaction between thymidine and uracil possessing a large functional fluorescent group, 5-(coumarin-7-oxyhex-5-yn) uracil (C4U). Conversion to 2′-deoxy-[5-(coumarin-7-oxyhex-5-yn)] uridine (dRC4U) was drastically enhanced by DMSO addition. Docking simulations between dRC4U and E. coli PNP (PDB 3UT6) showed the uracil moiety in the active-site pocket of PNP with the fluorescent moiety at the entrance of the pocket. Thus, the bulky fluorescent moiety has little influence on the coupling reaction. In summary, we have developed an efficient method for producing unnatural nucleosides, including purine derivatives and modified uracil, using PNP.

5-iodo-4-thio-2′-deoxyuridine as a sensitizer of X-ray induced cancer cell killing

Makurat, Samanta,Spisz, Paulina,Kozak, Witold,Rak, Janusz,Zdrowowicz, Magdalena

, (2019/05/10)

Nucleosides, especially pyrimidines modified in the C5-position, can act as radiosensitizers via a mechanism that involves their enzymatic triphosphorylation, incorporation into DNA, and a subsequent dissociative electron attachment (DEA) process. In this paper, we report 5-iodo-4-thio-2′-deoxyuridine (ISdU) as a compound that can effectively lead to ionizing radiation (IR)-induced cellular death, which is proven by a clonogenic assay. The test revealed that the survival of cells, pre-treated with 10 or 100 μM solution of ISdU and exposed to 0.5 Gy of IR, was reduced from 78.4% (for non-treated culture) to 67.7% and to 59.8%, respectively. For a somewhat higher dose of 1 Gy, the surviving fraction was reduced from 68.2% to 54.9% and to 40.8% for incubation with 10 or 100 μM ISdU, respectively. The cytometric analysis of histone H2A.X phosphorylation showed that the radiosensitizing effect of ISdU was associated, at least in part, with the formation of double-strand breaks. Moreover, the cytotoxic test against the MCF-7 breast cancer cell line and human dermal fibroblasts (HDFa line) confirmed low cytotoxic activity of ISdU. Based on the results of steady state radiolysis of ISdU with a dose of 140 Gy and quantum chemical calculations explaining the origin of the MS detected radioproducts, the molecular mechanism of sensitization by ISdU was proposed. In conclusion, we found ISdU to be a potential radiosensitizer that could improve anticancer radiotherapy.

Direct incorporation and extension of a fluorescent nucleotide through rolling circle DNA amplification for the detection of microRNA 24-3P

Le, Binh Huy,Seo, Young Jun

supporting information, p. 2035 - 2038 (2018/05/04)

We designed and synthesized several fluorescent nucleotides from thiophene, anthracene and pyrene, which have different sizes, and screened their incorporation and extension capability during the rolling circle amplification of DNA. The thiophene-based fluorescent nucleotide (dUthioTP) could highly incorporate and extended into the rolling circle DNA product, while other fluorescent nucleotides (dUanthTP, and dUpyrTP) could not. This dUthioTP fluorescent nucleotide could be used for the detection of miRNA 24-3P, which is related PRRSV. This direct labeling system during rolling circle DNA amplification exhibited an increased fluorescence signal showing gel formation for the detection of miRNA 24-3P. This direct labeling system is a very simple and cost-efficient method for the detection miRNA 24-3P and also exhibited highly sensitive and selective detection properties.

Diverse size approach to incorporate and extend highly fluorescent unnatural nucleotides into DNA

Le, Binh Huy,Koo, Ja Choon,Joo, Han Na,Seo, Young Jun

supporting information, p. 3591 - 3596 (2017/06/13)

We have prepared a series of size-diverse unnatural nucleotides containing fluorescent (dApyrTP, dUpyrTP, dUantTP, dUthiTP) and quencher (dUazoTP) units, as well as nucleotides presenting small functional groups (dAethTP, dAoctTP, dUethTP, dUiodTP), all based on deoxyadenosine and deoxyuridine, and examined their suitability for use in enzymatic incorporation and extension into DNA. We observed a size-dependence of the incorporation and extension capability (following the order dUiodTP?=?dUethTP?=?dUthiTP?>?dUazoTP?>?dUpyrTP?>?dUantTP) during primer extension. This result was supported by circular dichroism (CD) spectra, which revealed a trend in the different B-form DNA structures depending on the size of the unit at the 5-position of the deoxyuridine (dUiodTP?>?dUethTP?>?dUthiTP?>?dUpyrTP), obtained from the PCR products. Interestingly, dUthiTP could be incorporated and extended into long DNA strands during primer extension and even PCR amplification, with CD spectroscopy confirming a stable secondary B-form duplex DNA structure. We observed full-length extension products even when combining dUthiTP with a template containing 24 continuous dA units during the primer extension. Thus, we believe that dUthiTP is a promising fluorescent nucleotide for a diverse range of biological applications requiring multiple incorporation and extension directly without disruption of B-form DNA structures.

A comparison between immobilized pyrimidine nucleoside phosphorylase from Bacillus subtilis and thymidine phosphorylase from Escherichia coli in the synthesis of 5-substituted pyrimidine 2′-deoxyribonucleosides

Serra, Immacolata,Bavaro, Teodora,Cecchini, Davide A.,Daly, Simona,Albertini, Alessandra M.,Terreni, Marco,Ubiali, Daniela

, p. 16 - 22 (2013/10/22)

Pyrimidine nucleoside phosphorylase from Bacillus subtilis (BsPyNP, E.C. 2.4.2.3) and thymidine phosphorylase from Escherichia coli (EcTP, E.C. 2.4.2.4) were used, as immobilized enzymes, in the synthesis of 5-halogenated pyrimidine 2′-deoxyribonucleosides (14-18) by transglycosylation in fully aqueous medium. From the comparative study of the two biocatalysts, no remarkable differences emerged about their substrate specificity, bioconversion yield, stability in organic cosolvents (DMF and MeCN). Moreover, both biocatalysts could be recycled for at least 5 times with no loss of the productivity. Both enzymes do not accept arabinonucleosides and 2′,3′- dideoxynucleosides as substrates, whereas they catalyze bioconversions involving 5′-deoxyribonucleosides and 5-halogenated uracils. The synthesis of compounds 14-18 proceeded at a similar conversion (33-68% for BsPyNP and 25-62% for EcTP, respectively). Immobilization was found to exert, for both the biocatalysts, a dramatic enhancement of stability upon incubation in MeCN. Optimization of 5-fluoro-2′-deoxyuridine (14) synthesis (pH 7.5, 10 mM phosphate buffer, nucleoside/nucleobase 3:1 molar ratio) and subsequent scale-up afforded the target compound in 73% (EcTP) or 76% (BsPyNP) conversion (about 9 g/L).

Synthesis of novel nucleoside 5′-triphosphates and phosphoramidites containing alkyne or amino groups for the postsynthetic functionalization of nucleic acids

Vasilyeva, Svetlana V.,Budilkin, Boris I.,Konevetz, Dmitrii A.,Silnikov, Vladimir N.

body text, p. 753 - 767 (2012/07/28)

A series of novel nucleoside 5′-triphosphates and phosphoramidites containing alkyne or amino groups for the postsynthetic functionalization of nucleic acids were designed and synthesized. For this purpose, the new 3-aminopropoxypropynyl linker group was used. It contains two alternative functional capabilities: an amino group for the reaction of amino-alkynyl- modified oligonucleotides with corresponding activated esters and an alkyne group for the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. It was shown that a variety of methods of the attachment of the new linker can be used to synthesize a diversity of modified pyrimidine nucleosides. Copyright Taylor and Francis Group, LLC.

Ionic liquid mediated synthesis of 5-halouracil nucleosides: Key precursors for potential antiviral drugs

Kumar, Vineet,Malhotra, Sanjay V.

experimental part, p. 821 - 834 (2010/08/20)

Synthesis of antiviral 5-halouracil nucleosides, also used as key precursors for the synthesis of other potential antiviral drugs, has been demonstrated using ionic liquids as convenient and efficient reaction medium.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54-42-2